Clover Health Investments, Corp. (CLOV) stock
CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
$4.96+0.08 (+1.64%)
Close on Nov 13, 2026Market cap $2.63BP/E 496.0Yield –
Clover Health Investments shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Clover Health Investments's shares outstanding was 557M at Sep 30, 2026. For fiscal 2025 it was 512M, up 4.5% from the year before. The highest annual figure on record is 512M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 512M | +4.5% |
| FY2024 | Dec 31, 2024 | 490M | +1.6% |
| FY2023 | Dec 31, 2023 | 482M | +1.2% |
| FY2022 | Dec 31, 2022 | 476M | +15.3% |
| FY2021 | Dec 31, 2021 | 413M | +365.6% |
| FY2020 | Dec 31, 2020 | 89M | +1.0% |
| FY2019 | Dec 31, 2019 | 88M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 557M | +8.7% |
| Q2 FY2026 | Jun 30, 2026 | 545M | +7.2% |
| Q1 FY2026 | Mar 31, 2026 | 533M | +7.1% |
| Q4 FY2025 | Dec 31, 2025 | 517M | +4.6% |
| Q3 FY2025 | Sep 30, 2025 | 513M | +4.6% |
| Q2 FY2025 | Jun 30, 2025 | 509M | +2.8% |
| Q1 FY2025 | Mar 31, 2025 | 497M | +2.2% |
| Q4 FY2024 | Dec 31, 2024 | 495M | +1.8% |
| Q3 FY2024 | Sep 30, 2024 | 490M | +2.0% |
| Q2 FY2024 | Jun 30, 2024 | 495M | +3.3% |
| Q1 FY2024 | Mar 31, 2024 | 486M | +1.6% |
| Q4 FY2023 | Dec 31, 2023 | 486M | +1.6% |
| Q3 FY2023 | Sep 30, 2023 | 481M | +0.6% |
| Q2 FY2023 | Jun 30, 2023 | 479M | +0.7% |
| Q1 FY2023 | Mar 31, 2023 | 479M | +1.2% |
| Q4 FY2022 | Dec 31, 2022 | 478M | +13.7% |
| Q3 FY2022 | Sep 30, 2022 | 478M | +15.2% |
| Q2 FY2022 | Jun 30, 2022 | 476M | +16.6% |
| Q1 FY2022 | Mar 31, 2022 | 473M | +25.7% |
| Q4 FY2021 | Dec 31, 2021 | 420M | +372.8% |
| Q3 FY2021 | Sep 30, 2021 | 415M | +67.1% |
| Q2 FY2021 | Jun 30, 2021 | 408M | +68.2% |
| Q1 FY2021 | Mar 31, 2021 | 376M | +325.9% |
| Q4 FY2020 | Dec 31, 2020 | 89M | – |
| Q3 FY2020 | Sep 30, 2020 | 248M | – |
| Q2 FY2020 | Jun 30, 2020 | 243M | – |
| Q1 FY2020 | Mar 31, 2020 | 88M | – |
See a number that looks wrong?